Abstract:Background Pinellia pedatisecta Schott extract (PE) is extracted from Pinellia pedatisecta Schott (PPS), a traditional Chinese medicinal plant with the potential for direct anticancer effects or eliciting an anti-tumor response by activating the immune system. Purpose To explore PE's ability and mechanism to reconstruct cisplatin's immunogenicity. Methods Cervical cancer cells were treated with cisplatin (CDDP) and/or PE. The exposure of calreticulin (CRT) on cell membrane was investigated by flow cytometry. The extracellular of ATP and HMGB1 was investigated by Western blot analysis, immunofluorescence and ELISA assay. Changes in immune profiles were using flow cytometry in vaccination and anti-tumor assays in vivo . Lastly, the mechanism of PE influenced the ROS/ERS pathway was examined by ROS assay kit, flow cytometry and Western blotting. Results PE treatment induced translocation of CRT from the endoplasmic reticulum to the cell membrane of tumor cells, concomitantly triggering immunogenic cell death (ICD). In terms of mechanisms, endoplasmic reticulum (ER) stress relievers could impede the ability of PE to induce immunogenicity. This indicates that PE is activated by ER stress, leading to subsequent induction of ICD. Upon analyzing RNA-seq data, it was observed that PE primarily induces programmed cell death in tumors by impeding upstream antioxidant mechanisms. Additionally, it transforms dying tumor cells into vaccines, activating a series of immune responses. Conclusions This study observed for the first time that PE-induced CRT exposure on the membrane of cervical cancer cells compensates for the defect of nonimmunogenic cell death inducer CDDP thereby stimulating potent ICD. This ability restores the immunogenicity of CDDP through ER stress induced by the ROS signal. ROS played a role in PE's ability to induce ICD, leading to increased expression of ER stress-related proteins, including ATF3 and IRE-1α. PE exerted anti-cancer effects by increasing the ROS levels, and ROS/ERS signaling may be a potential avenue for cervical cancer treatment. Hence, the synergistic use of PE and CDDP holds potential for enhancing immunochemotherapy in cancer treatment.

[Effects and side effects of hypertensive intra-arterial chemotherapy (CDDP, PEP) in advanced cancer of the uterine cervix]

[Effects of Cisplatin on Telomerase Activity of Human Choroidal Melanoma Cells].

[The Effect of Carboplatin Combined Chemotherapy on Renal Function in Patients with Ovarian Carcinoma].

[Effects of Fractionated Low Dose Cisplatin on Renal Functions of Patients with Gastric Carcinoma].

Pharmacokinetics and safety of cyclophosphamide and docetaxel in a hemodialysis patient with early stage breast cancer: a case report

Effects of Cisplatin on the Contractile Function of Thoracic Aorta of Sprague-Dawley Rats.

Nephrotoxicity and Long-Term Survival Investigations for Patients with Peritoneal Carcinomatosis Using Hyperthermic Intraperitoneal Chemotherapy with Cisplatin: A Retrospective Cohort Study.

Intra-Arterial Infusion Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Preliminary Experience on the Safety, Efficacy, and Clinical Outcomes

Initial Results of Intra-arterial Chemotherapy for Poorly Differentiated Bladder Transitional Cell Carcinoma

Pelvic Irradiation Modulates the Pharmacokinetics of Cisplatin in the Plasma and Lymphatic System.

Cisplatin causes erectile dysfunction by decreasing endothelial and smooth muscle content and inducing cavernosal nerve senescence in rats

The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice

Intra-arterial Chemotherapy Followed by Radical Hysterectomy for Massive Cervical Cancer in stage ⅠB-ⅡB

PKPD Modeling and Dosing Considerations in Advanced Ovarian Cancer Patients Treated with Cisplatin-Based Intraoperative Intraperitoneal Chemotherapy

Combining Cisplatin with Pinellia pedatisecta Schott Lipid-Soluble Extract Induces Tumor Immunogenic Cell Death in Cervical Cancer

Tolerability, Efficacy and Feasibility of Concurrent Gemcitabine and Cisplatin (CGP) Combined With Intensity Modulated Radiotherapy for Loco-Regionally Advanced Carcinoma of the Cervix

Synergistic Cytotoxic Effects of a Combined Treatment of a Pinellia Pedatisecta Lipid-Soluble Extract and Cisplatin on Human Cervical Carcinoma in Vivo

Primary percutaneous coronary intervention and intravascular ultrasound imaging for coronary thrombosis after cisplatin-based chemotherapy

Interactions of Analgesics with Cisplatin: Modulation of Anticancer Efficacy and Potential Organ Toxicity

Treatment Tolerance and Side Effects of Intraperitoneal Carboplatin and Dose-Dense Intravenous Paclitaxel in Ovarian Cancer

The effects of intra-arterial chemotherapy on bladder preservation in patients with T1 stage bladder cancer